This case report describes a light pink plaque underneath an atrophied and broken nail plate that was surrounded by depigmentation. https://ja.ma/43HeT1V
JAMA Dermatology
图书期刊出版业
Chicago，Illinois 13,651 位关注者
A member of the JAMA Network, which includes JAMA, 11 specialty journals, and JAMA Network Open.
关于我们
JAMA Dermatology is published online weekly, every Wednesday, and in 12 print/online issues a year. The journal receives more than 7.2 million annual article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program. JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. The journal's acceptance rate is 10%. The median time to first decision is 4 days, and 47 days with review. The Journal Impact Factor is 10.9, one of the highest ranking among dermatology journals. All articles are published online first. Kanade Shinkai, MD, PhD, UCSF Department of Dermatology, San Francisco, California, is the editor in chief.
- 网站
-
https://jamanetwork.com/journals/jamadermatology
JAMA Dermatology的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 5,001-10,000 人
- 总部
- Chicago，Illinois
- 创立
- 1882
- 领域
- Dermatology
动态
-
Most viewed in the last 7 days from JAMA Dermatology: In this retrospective cohort study, there was no increased risk of MACE in patients with nicotinamide exposure. https://ja.ma/3F8oUuB
-
-
Systematic review: There is still an unmet need for high-quality validation studies on the internal structure of alopecia areata–specific patient-reported outcome measures. https://ja.ma/41x5WFl
-
-
Systematic review and meta-analysis: At-home red and blue LED devices are safe and effective for treating mild to moderate acne, reducing both inflammatory and noninflammatory lesions. https://ja.ma/3F7xE47
-
-
DFD-29 was superior in efficacy to both doxycycline and placebo and demonstrated a favorable risk-benefit profile in the treatment of papulopustular rosacea. https://ja.ma/3QL8ZoI
-
-
Rituximab is effective and safe for treating pemphigus foliaceus (PF) and pemphigus vulgaris (PV), with PF patients showing lower relapse rates and higher sustained remission compared to PV patients. https://ja.ma/3DmCVUV
-
-
Amjevita and Imraldi were as effective as Humira for both new starters and patients switching to biosimilars from Humira for psoriasis. https://ja.ma/41pYTyq
-
-
Risk of melanoma-related death increased significantly for patients with primary tumors of 0.8 to 1.0 mm in thickness. https://ja.ma/4gZPiUy
-
-
This case report describes a woman in her 50s with type 2 diabetes who presented with multiple erythematous dome-shaped umbilicated papules and nodules with scablike central plugs on the trunk and limbs. https://ja.ma/3XsRiOf
-
-
Dermatomyositis or clinically amyopathic DM (CADM) was as misdiagnosed as other inflammatory skin diseases, particularly CADM. https://ja.ma/4kkk2Th
-